πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9057054

Antigen-specific long-term memory T-cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8779095

LAT adapter molecule for enhanced T-cell signaling and method of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685404

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664251

Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

The Regents of the University of California Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663968

Simian T-cell lymphotropic virus

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998926

Dimerized T-cell receptor fragment, its compositions and use

The Arizona Boad of Regents on Behfl of the University of Arizona Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306804

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175838

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America represented by the Department of Health and Human Services Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7052703

T-cell receptorΞ³ alternate reading frame protein, (TARP) and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6660719

Inhibiting T-Cell proliferation

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656915

Inhibiting T-cell proliferation

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656471

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6517839

Methods for inducing interleukin-12 and a type1/Th1 T-cell response

The Regents of the University of California Β· Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6319496

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired